Bio Protocol (BIO) is revolutionizing biotechnology by merging decentralized finance (DeFi) with decentralized science (DeSci). Its mission is to accelerate biotech advancements by enabling global communities—including patients, scientists, and investors—to collectively fund, develop, and own tokenized biotech projects and intellectual property (IP).
The BIO token serves as a governance tool, granting holders the ability to influence decisions within various BioDAOs—decentralized autonomous organizations focused on specific biotech areas. Token holders can signal support for particular BioDAOs and gain early access to their funding rounds, fostering a collaborative environment for scientific innovation.
Scheduled for listing on major exchanges like Binance, Solana, and Base on January 3, 2025, BIO is poised to make a significant impact in the crypto and biotech sectors. The initial circulating supply is set at approximately 1.3 billion tokens, representing 39.05% of the total supply.
By integrating blockchain technology with scientific research, Bio Protocol aims to address critical gaps in traditional funding mechanisms, particularly in areas such as rare diseases and longevity research. This innovative approach not only democratizes access to biotech investments but also accelerates the development of life-saving therapies.
As the DeSci movement gains momentum, Bio Protocol stands at the forefront, offering a unique opportunity for individuals to participate in and benefit from the future of scientific research and biotechnology.